dr pradeep suryawanshi professor amp head department of
play

Dr. Pradeep Suryawanshi Professor & Head, Department of - PowerPoint PPT Presentation

PDA: whom, when and how to treat Dr. Pradeep Suryawanshi Professor & Head, Department of Neonatalogy, BVU Medical college, Pune Senior Consultant Neonatologist, Sahyadri Hospital, Pune Chief Patron & Consultant Neonatologist, Noble


  1. PDA: whom, when and how to treat Dr. Pradeep Suryawanshi Professor & Head, Department of Neonatalogy, BVU Medical college, Pune Senior Consultant Neonatologist, Sahyadri Hospital, Pune Chief Patron & Consultant Neonatologist, Noble Hospital, Pune Mentor, Department of Pediatrics, BLDE University, Bijapur 10/3/2016 1

  2. Learning Objectives • Why – Why treat a PDA? • What – Can we identify a PDA that should be treated? • When – Can we identify the best time to treat? • With what – Do we have a treatment that has an acceptable risk/benefit ratio? 10/3/2016 2

  3. Effects of PDA 10/3/2016 3

  4. PDA Morbidity 10/3/2016 4

  5. PDA Management Potential benefits of treatment • Avoid hypote�sio� • ‘edu�ed severe IVH �Prophyla�ti�� • ‘edu�ed pul�o�ary hae�orrhage • ‘edu�ed gut �o�pli�atio�s • ‘edu�ed surgi�al ligatio� • Possi�ly redu�ed CLD if �losed earlier 10/3/2016 5

  6. 10/3/2016 6

  7. PDA Evaluation • In first 72 hrs PDA can ONLY be diagnosed with echocardiography as typical signs & symptoms of PDA shunting are absent • Haemodynamic significance precedes development of clinical signs by an average of 2 days (range 1 – 4 days) 10/3/2016 7

  8. 10/3/2016 8

  9. ECHO: What is a “significant” PDA? 10/3/2016 9

  10. Is the ductus patent ? Imaging the duct – 2 D A �three - legged stool� appeara��e - Right pulmonary artery (RPA) and left pulmonary artery (LPA) forming the right and middle legs, and the duct forming the third leg 10/3/2016 10

  11. Is the ductus patent ? Imaging the duct – Colour Colour Doppler ultrasound - Bright flare of colour - Detection of a patent duct easy 10/3/2016 11

  12. Color Doppler duct diameter Small duct Big duct 10/3/2016 12

  13. Size of Duct Message 4- Duct Diameter < 1.5 mm – Usually insignificant Duct Diameter 1.5 – 2 mm – Significant variable / Use with DA flow Duct Diameter > 2.0 mm – Usually Significant 10/3/2016 13

  14. Range of ductal constriction at 5 hours < 30 weeks, N= 124 Poor early constriction Tend to stay patent Good early constriction Tend to close

  15. Direction and Pattern of ductal shunt Analysis of the direction of ductal shunting requires PD/CW Sampling gate placed at pulmonary end of duct 10/3/2016 15

  16. Pure Left to Right shunt 10/3/2016 16

  17. Bidirectional shunt Pulmonary pressures are still below systemic pressures There is a period in early systole when pulmonary pressures > systemic pressures, there is an early period of a R to L shunt, followed by L to R shunt 10/3/2016 17

  18. 10/3/2016 18

  19. Evaluation of chamber dilatation : LA: AO 19

  20. LA: AO - > 1.4 Ao Ao LA LA 10/3/2016 20

  21. LVEDD/Ao >2.1 10/3/2016 21

  22. 10/3/2016 22

  23. 10/3/2016 23

  24. PDA: (“Ductal steal”)  Diastolic aortic pressure is low with a large left to right ductal shunt - ductal steal  Steal - Blood passing down the descending aorta during systole goes backwards up the arterial duct and into the pulmonary arteries during diastole  Relative under perfusion of ALL systemic arteries  Co��o�ly �i�terrogated� arteries:  Descending aorta/Mesenteric/Renal/Anterior Cerebral 10/3/2016 24

  25. Descending aorta flow 10/3/2016 25

  26. Descending aorta flow 10/3/2016 26

  27. Abnormal flow pattern – Absent ACA 10/3/2016 27

  28. Abnormal flow pattern – REDF SMA 10/3/2016 28

  29. Abnormal flow pattern – REDF Renal Artery 10/3/2016 29

  30. 10/3/2016 30

  31. Take Home message Sehgal & McNamara Eur J Pediatrics. 2009 10/3/2016 31

  32. 10/3/2016 32

  33. Shahab Noori 2014 10/3/2016 33

  34. Argument to treat early • Effects of shunt – Short term – Hypotension, PH, IVH, Ductal steal – Medium term – CLD, PVL • Effects of treatment – Acute – no increase shown in prophylaxis trials (NEC, SIP) – Long term – no difference in ND outcome (TIPP trial) • Benefits to earlier treatment – Better timing – More efficacious – In right time frame for other benefits – reduced IVH, PH, hypotension 34

  35. Sellmer et al. ADC F&N 2013 10/3/2016 35

  36. 10/3/2016 36

  37. With what ? Treatment of PDA • Conservative – positive pressure – fluid restri�tio�/�he�i�al �a�di�g�↑pCO2, ↓pO2� – Diuretics – increase hematocrit • Medical – Indomethacin – Ibuprofen – Intravenous/Oral – Paracetamol • Surgical ligation 10/3/2016 37

  38. Ibuprofen is as effective as indomethacin in closing a PDA and currently appears to be the drug of choice. Ibuprofen reduces the risk of NEC and transient renal insufficiency. Oro-gastric administration of ibuprofen appears as effective as iv administration. 10/3/2016 38

  39. Key Messages • PDA is not benign and increases risk of death and complications of prematurity • Clinical and echocardiography criteria differ for early targeted and late symptomatic treatment • Late treatment of a symptomatic PDA does not improve clinical & long term outcomes • If PDA unlikely to close spontaneously then treatment before it becomes symptomatic may be beneficial – trials are needed to assess this approach

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend